AstraZeneca plc vs Tripadvisor Inc Common Stock — how do they compare? AstraZeneca plc trades at $158.56 (market cap $250.84B), while Tripadvisor Inc Common Stock trades at $11.04 (market cap $1.26B). The key difference: AstraZeneca plc is far larger — about 199.1× Tripadvisor Inc Common Stock's market cap, and AstraZeneca plc pays a 1.97% dividend while Tripadvisor Inc Common Stock pays none. Which is the better fit depends on your goals.
| AZN | TRIP | |
|---|---|---|
Market Cap | $250.84B | $1.26B |
Sector | Health | Consumer Cyclical |
52-Week High | $209.48 | $19.14 |
52-Week Low | $147.06 | $9.24 |
Enterprise Value | $278.12B | $1.31B |
Dividend Yield | 1.97% | — |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →